27. van Gils m.p., cornel e.B., hessels D., peelen W.p., Witjes J.a., mulders p.f. et al. molecular pca3 diagnostics on prostatic fluid. <...> The use of pca3 in the diagnosis of prostate cancer. <...> Groskopf J., aubin s.m., Deras i.l., Blase a., Bodrug s., clark c. et al. apTima pca3 molecular urine Test: development of a method to aid in the diagnosis of prostate cancer. <...> 30. hessels D., van Gils m.p., van hooij o., Jannink s.a., Witjes J.a., verhaegh G.W. et al. predictive value of pca3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer. <...> Tomlins s.a., rhodes D.r., perner s., Dhanasekaran s.m., mehra r., sun X.W. et al. recurrent fusion of Tmprss2 and eTs transcription factor genes in prostate cancer. <...> 33. leyten G.h., hessels D., Jannink s.a., smit f.p., de Jong H., cornel e.B. et al. prospective multicentre evaluation of pca3 and Tmprss2-erg gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. <...> Detection of Tmprss2-erG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. <...> 35. rajput a.B., miller m.a., De luca a., Boyd n., leung s., hurtadocoll a. et al. frequency of the Tmprss2-erG gene fusion is increased in moderate to poorly differentiated prostate cancers. <...> Tmprss2-erG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. <...> 37. leyten G.h., hessels D., Jannink s.a., smit f.p., de Jong H., cornel e.B. prospective multicentre evaluation of pca3 and Tmprss2erG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. <...> РЕФЕРЕНСНЫЕ <...>